Article
Excellus BlueCross BlueShield says it could save $460 million to $1 billion per year if its customers use more generic drugs instead of name-brand prescriptions, according to a new report from the insurer.
That's because the average 30-day costs for brand drugs have risen exponentially--a 73% increase from $120 to $208 over the last 5 years--compared to generics, which actually decreased 7.5% from $19 to $18, the Rochester Democrat and Chronicle reports.
Read more at: http://tinyurl.com/6uav2ts
Source: Fierce Health Payer
Adding to this cost trend is the fact that "no less than 42 brand-name drugs either have or will become available as generics in 2011 and 2012, which easily can mean a 2-point to 4-point increase in the upstate New York generic fill rate," says Joel Owerbach, Excellus vice president and chief pharmacy officer.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.